Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model.
Sebastian WursterRussell E LewisNathaniel D AlbertDimitrios P KontoyiannisPublished in: Antimicrobial agents and chemotherapy (2019)
Breakthrough mucormycosis in patients receiving isavuconazole prophylaxis or therapy has been reported. We compared the impact of isavuconazole and voriconazole exposure on the virulence of clinical isolates of Aspergillus fumigatus and different Mucorales species in a Drosophila melanogaster infection model. In contrast to A. fumigatus, a hypervirulent phenotype was found in all tested Mucorales upon preexposure to either voriconazole or isavuconazole. These findings may contribute to the explanation of breakthrough mucormycosis in isavuconazole-treated patients.
Keyphrases
- drosophila melanogaster
- escherichia coli
- pseudomonas aeruginosa
- staphylococcus aureus
- end stage renal disease
- newly diagnosed
- ejection fraction
- men who have sex with men
- antimicrobial resistance
- biofilm formation
- magnetic resonance
- peritoneal dialysis
- prognostic factors
- stem cells
- magnetic resonance imaging
- mesenchymal stem cells
- cell therapy
- genetic diversity